Boardroom Alpha
Start trial
Research library
SPACs · Oct 27, 2026

SPAC Market Update October 27, 2026: BEAG Extension Clears After $165M Redemptions

Bold Eagle Acquisition Corp (BEAG) won approval to extend its deadline to June 25, 2027, on October 27, 2026, after $165M in redemptions. BEAG is pursuing REDLattice, and the vote removed 15,397,025 shares from trust at $10.70 per share.

SPAC IPO Update — October 27, 2026

No SPAC IPOs priced on October 27, 2026; October MTD now stands at 4 IPOs totaling $491M over 27 sessions.

SPAC IPO Count

Monthly IPOs (last 13 months)
Latest: 4•Prior: 5•MoM: -1
14
Oct ’25
10
Nov ’25
22
Dec ’25
24
Jan ’26
27Peak
Feb ’26
11
Mar ’26
16
Apr ’26
20
May ’26
19
Jun ’26
18
Jul ’26
12
Aug ’26
5
Sep ’26
4
Oct ’26
Source: Boardroom Alpha
IPO Activity SnapshotMonth-to-date: 4 IPOs ($491M) vs. first 27 days of last month 5 ($940M) · 12-mo avg: 16/mo
$ totals include underwriter over-allotment.

Daily SPAC Update — October 27, 2026

SPAC VOTE RESULTS
BOLD EAGLE ACQUISITION CORP (BEAG) * Extend to June 25, 202715,397,025 redeemed · $164,748,168 removed · trust $10.70
OAKTREE ACQUISITION CORP III LIFE SCIENCES (OACC) * Extend to May 25, 202711,331,102 redeemed · $122,432,557 removed · trust $10.81

SPAC DEALS ANNOUNCED
October 26 | Amanat Acquisition Corp (AMAN) + Corxel PharmaceuticalsCorxel Pharmaceuticals is a clinical-stage biopharmaceutical company that develops oral medicines for obesity and related cardiometabolic conditions. Its lead product candidate, CX11, is a once-daily oral GLP-1 receptor agonist that has completed Phase 2 clinical development in the United States and Phase 3 clinical development in Asia. The company is also advancing CX12, an investigational oral amylin receptor agonist currently in preclinical development.

SPAC DEAL & EXTENSION VOTES SET
Globa Terra Acquisition Corp (GTERA) * EXTENSION VOTE SET: November 9, 2026 * trust $10.48
Gp-Act III Acquisition Corp (GPAT) * EXTENSION VOTE SET: November 12, 2026 * trust $11.07

EXTENSION VOTES
CACTUS ACQUISITION CORP 1 LTD (CCTSF)vote October 27, 2026 -> extend from November 2, 2026 to November 2, 2027

OTHER SPAC NEWS
AMANAT ACQUISITION CORP (AMAN) * Merger Agreement
AMANAT ACQUISITION CORP (AMAN) * Investor Deck
GIGCAPITAL9 CORP (GIX) * Non-Binding LOIGigCapital9 announces a non-binding LOI for a potential business combination, contingent on definitive agreements, approvals, and financing.
K&F GROWTH ACQUISITION CORP II (KFII) * Media TranscriptDavid’s Bridal to spin off Pearl as a public company via SPAC with K&F Growth II; Pearl owns DB brand/IP.

SPAC LISTING RULE NOTICES
CHARLTON ARIA ACQUISITION CORP (CHAR) * Listing Rule NoticeCharlton Aria reconstituted its audit committee with independent directors and believes Nasdaq compliance is restored as of Oct 22, 2026.
YHN ACQUISITION I LTD (YHNA) * Listing Rule NoticeNasdaq delists YHN Acquisition I Limited after failing to regain minimum market value requirements; plans OTC quotation.

SPAC Executive & Director Moves — October 27, 2026

SPAC Executive & Director Moves
Company Ticker Moves
CHARLTON ARIA ACQUISITION CORP CHAR
  • On October 22, 2026, Kyoung Tak Kim exited the audit committee and joined the compensation committee, while Wang Jo Cha joined the audit committee and exited the compensation committee; both changes were effective immediately. Kim continues as a company director, and no board-seat changes were disclosed.  (view source)
CHURCHILL CAPITAL CORP XIII XIII
  • The text discloses William Sherman and Paul Lapping entering or continuing as directors, with director agreements providing $75,000 annual cash compensation beginning October 1, 2026. The provided text specifically supplies biographical background for Paul Lapping; it does not state the appointment effective date for either director in the excerpt.  (view source)
PRAETORIAN ACQUISITION CORP PTOR
  • The filing discloses the resignations of Nicole Seligman, Erica Dorfman, Alex Elias, and Peter Ondishin on October 20, 2026. It also announces the appointment of Roger L. Cloutier, Jimmy Vaiopoulos, Charles P. Garcia, and Joseph Tonnos as directors, with Joseph Tonnos additionally entering as CFO, effective October 20, 2026.  (view source)
SOREN ACQUISITION CORP SORN
  • The filing discloses departures of directors Spencer Gerrol and Charles N. Kahn III, and CFO/director Jamie Weber, all effective October 20, 2026. It also discloses the appointment of Roger Cloutier Jr., Austin Criden, and Joseph Tonnos as directors, with Tonnos additionally appointed CFO, effective October 20, 2026; the provided text includes background only for Roger Cloutier Jr.  (view source)
Source: SEC EDGAR filings via Boardroom Alpha

SPAC Movers — October 27, 2026

YESTERDAY’S TOP SPAC GAINERS
Company Ticker Change Price Stage
RF ACQUISITION CORP II RFAI 37.0% $ 35.83 Announced
RIBBON ACQUISITION CORP RIBB 18.3% $ 6.71 Announced
FUTURE VISION II ACQUISITION CORP FVN 5.4% $ 11.75 Announced
QUETTA ACQUISITION CORP QETA 3.1% $ 11.55 Announced
RISING DRAGON ACQUISITION CORP RDAC 2.7% $ 5.03 Announced
YESTERDAY’S TOP SPAC LOSERS
Company Ticker Change Price Stage
CALISA ACQUISITION CORP ALIS -8.5% $ 8.20 Announced
MELAR ACQUISITION CORP I MACI -7.1% $ 10.22 Announced
TCGX ACQUISITION CORP II TCXB -2.1% $ 10.27 Pre-Deal
AI INFRASTRUCTURE ACQUISITION CORP AIIA -1.3% $ 10.22 Pre-Deal
BOLD EAGLE ACQUISITION CORP BEAG -1.2% $ 10.39 Announced
Source: Boardroom Alpha market data

Frequently Asked Questions

  • How did BEAG‘s extension-vote redemptions compare with OACC today?
    Bold Eagle Acquisition Corp (BEAG) had $165M removed from trust, above Oaktree Acquisition Corp III Life Sciences (OACC)’s $122M extension-vote redemption today.
  • What happened at OACC‘s extension vote?
    Oaktree Acquisition Corp III Life Sciences (OACC) won approval to extend its deadline to May 25, 2027, with 11,331,102 shares redeemed and $122M removed from trust.
  • Which SPAC extension votes were scheduled today?
    Globa Terra Acquisition Corp (GTERA) set November 9, 2026, for an extension vote, and Gp-Act III Acquisition Corp (GPAT) set November 12, 2026, for an extension vote.
  • How many SPAC IPOs priced in October 2026 through October 27?
    4 SPAC IPOs raised $491M through October 27, 2026, including over-allotment, compared with 5 IPOs for $940M over the same 27-day span in September 2026.
  • What did the Nasdaq listing notices say today?
    Charlton Aria Acquisition Corp (CHAR) said it reconstituted its audit committee and believes Nasdaq compliance was restored as of October 22, 2026; YHN Acquisition I Ltd (YHNA) was delisted and plans OTC quotation.


Go deeper

SPAC data & trackers

Get it in your inbox

The Daily SPAC Update in your inbox

Every IPO, vote, and DeSPAC close — analyzed daily for finance professionals.

ShareXLinkedIn

Published Oct 27, 2026

More from SPACs

All research
SPACs · Oct 26, 2026

SPAC Market Update October 26, 2026: OACC Extension Clears with $122M Redemptions, AMAN-Corxel Deal

Oaktree Acquisition Corp III Life Sciences (OACC) won approval to extend its deadline to May 25, 2027, with $122M removed from trust and 11,331,102 shares redeemed. Separately,…

Read
SPACs · Oct 23, 2026

SPAC Market Update October 23, 2026: CHAR Extension Clears After $63M Redemptions

Charlton Aria Acquisition Corp (CHAR) won approval for its extension vote on October 23, 2026, with $63M removed from trust and 5,725,962 shares redeemed. The vote pushed CHAR’s…

Read
SPACs · Oct 21, 2026

SPAC Market Update October 21, 2026: TRAD to Merge with Korai Flix, SSEA Extension Redemptions

Apex Tech Acquisition Inc (TRAD) announced a merger with Korai Flix Inc, a South Korea-headquartered AI-powered interactive entertainment platform, on October 21, 2026; no…

Read
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer